S 5059 - 119

Introduced in Senate

A bill to amend the Public Health Service Act to streamline the review of biosimilar biological products.

Sections

Dollar amounts

Deadlines and effective dates

Jul 21, 2026

Text version date

Top statutory references

42 U.S.C. 262 1

Official source

Official PDF

Preview the source PDF from the official text formats without leaving this page, or open the original file in a new tab.

Open official PDF

Structured text

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [S. 5059 Introduced in Senate (IS)] 119th CONGRESS 2d Session S. 5059 To amend the Public Health Service Act to streamline the review of biosimilar biological products. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES July 21, 2026 Mrs. Moody (for herself, Ms. Alsobrooks, Mr. Scott of Florida, and Ms. Blunt Rochester) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Public Health Service Act to streamline the review of biosimilar biological products. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

Sec. 1.

SECTION 1. STREAMLINING BIOSIMILAR REVIEWS.

SECTION 1. STREAMLINING BIOSIMILAR REVIEWS.

Sec. 351

Section 351(k)(5) of the Public Health Service Act (42 U.S.C.

Section 351(k)(5) of the Public Health Service Act (42 U.S.C. 262(k)(5)) is amended-- (1) by striking subparagraph (B); and (2) by redesignating subparagraph (C) as subparagraph (B).

Cached official text analysis. This viewer uses cached official bill text and deterministic section, phrase, fiscal, agency, deadline, and statutory-reference extraction. The analysis is navigation support, not a legal interpretation; consult the official text for authoritative wording.

Disclaimer Report issue